Radium bromide the air causes this luminescence. Radium bromide is also very dangerous since the crystals occasionally explode. Helium gas evolved from alpha particles can accumulate within the crystals which cause them to weaken and rupture. Another property of radium bromide is its ability to crystallize from an aqueous solution. It forms a dihydrate, very similar to barium bromide. The chemical radium bromide is not found in nature; it is created. To extract radium from uranium or pitchblende ores, the most common practice is called the Curie method which it involves two major stages. The first stage is a chemical treatment to
Radium chloride radon gas which in turn was used as a cancer treatment. Radium-223 dichloride (USP, radium chloride Ra 223), tradename Xofigo (formerly Alpharadin), is an alpha-emitting radiopharmaceutical. Bayer received FDA approval for this drug to treat prostate cancer osteoblastic bone metastases in May 2013. Radium chloride Ra 223 is one of the most potent drugs known. One dose (50 kBq/kg) in an adult is about 60 nanograms; this amount is 1/1000 the weight of an eyelash (75 micrograms). Radium chloride Radium chloride (RaCl) is a chemical compound of radium and chlorine, and the first radium compound isolated in a pure state.